Pharmacokinetic Optimisation of Inhaled Steroid Therapy in Asthma
- 1 August 1993
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 25 (2) , 126-135
- https://doi.org/10.2165/00003088-199325020-00005
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.Thorax, 1991
- Inhaled corticosteroids, bone formation, and osteocalcinThe Lancet, 1991
- Inhaled corticosteroids, bone formation, and osteocalcinThe Lancet, 1991
- Steroid aerosols and cataract formation.BMJ, 1989
- Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.Thorax, 1987
- Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma.Thorax, 1986
- Failure of once daily inhaled corticosteroid treatment to control chronic asthma.Thorax, 1984
- Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonideJournal of Allergy and Clinical Immunology, 1982
- An objective assessment of the tube spacer in patients unable to use a conventional pressurized aerosol efficientlyRespiratory Medicine, 1981
- The effect of cortisone on bronchial asthmaJournal of Allergy, 1950